Feng, G
17 Therefore, physicians and pharmacists are encouraged to advise their patients taking exenatide to be aware of the signs and symptoms of acute pancreatitis and to seek prompt medical attention should they experience unexplained, persistent, severe abdominal pain, which may be accompanied by nausea, vomiting, and fever
GLP-1RAs dominate IGE-related reports Among the top 10 drugs associated with IGE events, five were GLP-1 receptor agonists: Dulaglutide: 262 cases Semaglutide: 246 cases Exenatide: 183 cases Tirzepatide: 181 cases Liraglutide: 110 cases Together, they accounted for 49.5% (982 of 1982) of the IGE reports among these top 10 drugs
In early trials of exenatide and liraglutide in Type 2 diabetes (T2D), these agents uniformly led to weight loss
Start Losing Weight With a $50 Credit No payment prior to consultation Speak to a specialist (888) 870-8005 The Sanctuary Wellness Institute is a telehealth medical weight loss provider offering physician-supervised programs that use GLP-1 (Semaglutide/Tirzepatide) medications, individualized meal planning, and ongoing clinical monitoring through telehealth
10.1016/s0140-6736(14)60976-4
